Rheumatology News Roundup: Crisis in Osteoporosis Care

Article

In this week's news roundup from Rheumatology Network, we highlight this week's leading stories including two stories on new developments in osteoporosis treatment. In one, a physician-scientist describes "a crisis in the treatment of osteoporosis" due to severe side effects. Learn more about this story and others in this week's news roundup.

Recent Videos
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
Related Content
Alex Rudge, PhD candidate, University of Bath

Arthritis Incidence in Psoriasis Higher Than EHR Records Suggest

Victoria Johnson
September 21st 2024
Article
Emerging Agents in the Treatment of Rheumatic Diseases

Emerging Agents in the Treatment of Rheumatic Diseases

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;Philip J. Mease, MD
October 2nd 2023
Podcast
Gout Prevalence to Increase by More Than 70% by 2050

Gout Prevalence to Increase by More Than 70% by 2050

Victoria Johnson
September 20th 2024
Article
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis

Nehad Soloman, MD, FACR;Andrew Sharobeem, DO, FACR;John B. Boone, MD, FACR;Madelaine Feldman MD, FACR
August 31st 2023
Podcast
Anne Constanze Regierer, MD, head, Registry Research in Rheumatology Research Group, Epidemiology program, German Rheumatism Research Centre Berlin, Germany

Subjective Tolerability Drives PsA Treatment Decisions in Cohort Study

Victoria Johnson
September 19th 2024
Article
Yuanteng Jeff Li, MD, RhMSUS, FACR, Assistant Professor, Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center,

IL-17/IL-23 Targeting Safely Managed PsA in 3 Patients With Cancer on Immune Checkpoint Inhibitor Therapy

Victoria Johnson
September 18th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.